Tag: NBTXR3

FDA Approved Nanobiotix for First Immuno-Oncology Trial
Healthcare
Healthcare

FDA Approved Nanobiotix for First Immuno-Oncology Trial

Pareesh Phulkar - January 12, 2018

Nanobiotix, a nanomedicine announced the approval of U.S. Food and Drug Administration (FDA) on December 26, 2017, for Investigational New Drug (IND) Application. NBTXR3 is a first…